Skip to Content

Tristel PLC TSNLF

Morningstar Rating
$5.08 −0.91 (15.19%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TSNLF is trading at a 29% premium.
Price
$5.08
Fair Value
$6.16
Uncertainty
High
1-Star Price
$1.76
5-Star Price
$5.74
Economic Moat
Ygjrm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TSNLF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$5.99
Day Range
$5.085.08
52-Week Range
$5.085.99
Bid/Ask
$0.01 / $8,006.32
Market Cap
$240.80 Mil
Volume/Avg
95,100 / 58,850

Key Statistics

Price/Earnings (Normalized)
42.91
Price/Sales
5.56
Dividend Yield (Trailing)
1.58%
Dividend Yield (Forward)
1.58%
Total Yield
1.58%

Company Profile

Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates majority of revenue from Hospital medical device decontamination.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
250

Comparables

Valuation

Metric
TSNLF
OM
AKT
Price/Earnings (Normalized)
42.91
Price/Book Value
6.211.296.99
Price/Sales
5.561.196.44
Price/Cash Flow
23.43
Price/Earnings
TSNLF
OM
AKT

Financial Strength

Metric
TSNLF
OM
AKT
Quick Ratio
3.934.270.74
Current Ratio
4.925.260.81
Interest Coverage
41.17−13.3911.08
Quick Ratio
TSNLF
OM
AKT

Profitability

Metric
TSNLF
OM
AKT
Return on Assets (Normalized)
17.36%−39.03%5.43%
Return on Equity (Normalized)
23.20%−72.89%14.42%
Return on Invested Capital (Normalized)
19.60%−44.98%10.12%
Return on Assets
TSNLF
OM
AKT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncPgcrdsjpXfrzb$135.3 Bil
BDX
Becton Dickinson & CoLrtggcrYjhrtx$67.8 Bil
ALC
Alcon IncSxhnlhzflShqmgm$39.1 Bil
RMD
ResMed IncXgwdzrybxQvyrhvl$31.9 Bil
CLPBY
Coloplast A/S ADRLfrpgbqdPpyf$27.8 Bil
WST
West Pharmaceutical Services IncYklbmknxjTlt$26.7 Bil
BAX
Baxter International IncTkdptpsdPftqwct$18.8 Bil
COO
The Cooper Companies IncDbzmnjmnzPpcvpqq$18.0 Bil
HOLX
Hologic IncDsqywzvNlkzpq$17.9 Bil
ATR
AptarGroup IncTvcqvjmvLpdgp$9.7 Bil

Sponsor Center